GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (LTS:0I3I) » Definitions » YoY Rev. per Sh. Growth

The Cooper (LTS:0I3I) YoY Rev. per Sh. Growth : 7.85% (As of Jan. 2024)


View and export this data going back to 2018. Start your Free Trial

What is The Cooper YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. The Cooper's YoY Rev. per Sh. Growth for the quarter that ended in Jan. 2024 was 7.85%.

The Cooper's Revenue per Share for the three months ended in Jan. 2024 was $4.66.


The Cooper YoY Rev. per Sh. Growth Historical Data

The historical data trend for The Cooper's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper YoY Rev. per Sh. Growth Chart

The Cooper Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.14 -7.64 19.73 13.43 8.39

The Cooper Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.56 5.53 9.62 9.10 7.85

The Cooper YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

The Cooper's YoY Rev. per Sh. Growth for the fiscal year that ended in Oct. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Oct. 2023 )
=(Revenue per Share (A: Oct. 2023 )-Revenue per Share (A: Oct. 2022 ))/ | Revenue per Share (A: Oct. 2022 ) |
=(18.038-16.642)/ | 16.642 |
=8.39 %

The Cooper's YoY Rev. per Sh. Growth for the quarter that ended in Jan. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Jan. 2024 )
=(Revenue per Share (Q: Jan. 2024 )-Revenue per Share (Q: Jan. 2023 )) / | Revenue per Share (Q: Jan. 2023 )) |
=(4.66-4.321)/ | 4.321 |
=7.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Cooper YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of The Cooper's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cooper (LTS:0I3I) Business Description

Traded in Other Exchanges
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (LTS:0I3I) Headlines

No Headlines